2020
DOI: 10.1016/j.ajhg.2020.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent De Novo NAHR Reciprocal Duplications in the ATAD3 Gene Cluster Cause a Neurogenetic Trait with Perturbed Cholesterol and Mitochondrial Metabolism

Abstract: Recent studies have identified both recessive and dominant forms of mitochondrial disease that result from ATAD3A variants. The recessive form includes subjects with biallelic deletions mediated by non-allelic homologous recombination. We report five unrelated neonates with a lethal metabolic disorder characterized by cardiomyopathy, corneal opacities, encephalopathy, hypotonia, and seizures in whom a monoallelic reciprocal duplication at the ATAD3 locus was identified. Analysis of the breakpoint junction frag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
48
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 39 publications
(51 citation statements)
references
References 22 publications
1
48
0
2
Order By: Relevance
“…Deletions between ATAD3B and ATAD3A lead to a fusion transcript under the regulation of the weaker ATAD3B promoter and thus show decreased expression of an ATAD3B/ATAD3A fusion protein that presumably is sufficient for fetal development but apparently cannot sustain life beyond the neonatal period [ 7 ]. The reciprocal, NAHR-mediated duplication at this locus (between ATAD3C exon 7 and the homologous ATAD3A exon 11, reciprocal to the ATAD3C-ATAD3A deletion described by Harel et al [ 12 ]) results in a fusion gene encoding a protein with multiple alterations at key functional residues [ 18 , 19 ]. We previously hypothesized that the fusion protein acts through a dominant negative mechanism [ 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…Deletions between ATAD3B and ATAD3A lead to a fusion transcript under the regulation of the weaker ATAD3B promoter and thus show decreased expression of an ATAD3B/ATAD3A fusion protein that presumably is sufficient for fetal development but apparently cannot sustain life beyond the neonatal period [ 7 ]. The reciprocal, NAHR-mediated duplication at this locus (between ATAD3C exon 7 and the homologous ATAD3A exon 11, reciprocal to the ATAD3C-ATAD3A deletion described by Harel et al [ 12 ]) results in a fusion gene encoding a protein with multiple alterations at key functional residues [ 18 , 19 ]. We previously hypothesized that the fusion protein acts through a dominant negative mechanism [ 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, the knockdown of ATAD3 has been associated with a reduction in mtDNA content [ 170 ]. In human fibroblasts that are either deficient for ATAD3 or harbour a duplication of the ATAD3 gene cluster, nucleoids were found to be enlarged and clustered together suggesting a role of ATAD3 and fusion in mtDNA distribution [ 171 , 172 ]. The knockout of ATAD3 in skeletal muscle has been associated with the progressive formation of mtDNA deletions and copy number depletion [ 173 ].…”
Section: Membrane Dynamics and The Organisation Of Mtdnamentioning
confidence: 99%
“…Affected individuals whose fibroblasts exhibited impaired cholesterol metabolism often presented with elevated urine levels of 3-methyglutaconic acid (3-MGA). 10,12,15 Interestingly, reading of this manuscript. We appreciate Dr. Sheng Zhang's kind gift of rabbit anti-Ref2(P)…”
Section: Drosophila Studies Of Missense Variantsmentioning
confidence: 99%
“…12 The reciprocal, NAHR-mediated duplication at this locus, between ATAD3C and ATAD3A, results in a fusion gene encoding a dysfunctional protein. 15 Homozygosity for presumed hypomorphic missense alleles (p.Thr53Ile, p.Thr84Met) leads to bilateral cataracts, hypotonia, ataxia and cerebellar atrophy. 10; 16 Finally, a recurrent de novo heterozygous missense variant (p.Arg528Trp) acts as an antimorph or dominant-negative allele and gives rise to a phenotypic spectrum including developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.…”
Section: Introductionmentioning
confidence: 99%